Opioid Litigation's Growing Strength: From Snowflakes To Blizzard

Infographic examines key opioid events since Purdue's 2007 settlement as legal actions snowball to include disclosures by DEA and wholesalers as well.

Opioid Law Concept 3D Illustration

Eleven years after Purdue Pharma LP pled guilty to marketing OxyContin as less addictive than other pain medicines the legal fallout has only intensified. Manufacturers and distributors are facing an ever-growing barrage of lawsuits and government prosecutors have launched new investigations of their sales and marketing practices. The expected settlements will not just have a financial impact on the firms involved, but may also set a precedent for what public health responsibilities companies are expected to bear.

OxyContin (oxycodone controlled-release) was approved by FDA in December 1995 as the first formulation of oxycodone that allowed dosing every...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet